Loading...
PURE Bioscience, Inc.
PURE•PNK
Consumer Defensive
Household & Personal Products
$0.07
$0.003(3.88%)
PURE Bioscience, Inc. (PURE) Financial Performance & Income Statement Overview
Review PURE Bioscience, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
4.58%
↑ 4.58%
Operating Income Growth
20.59%
↑ 20.59%
Net Income Growth
15.43%
↑ 15.43%
Operating Cash Flow Growth
22.79%
↑ 22.79%
Operating Margin
-134.68%
↓ 134.68%
Gross Margin
58.05%
↑ 58.05%
Net Profit Margin
-147.65%
↓ 147.65%
ROE
82.64%
↑ 82.64%
ROIC
-3029.41%
↓ 3029.41%
PURE Bioscience, Inc. (PURE) Income Statement & Financial Overview
Review PURE Bioscience, Inc.'s (PURE) income statement with detailed quarterly and annual figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $391000.00 | $556000.00 | $474000.00 | $441000.00 |
Cost of Revenue | $164000.00 | $231000.00 | $199000.00 | $183000.00 |
Gross Profit | $227000.00 | $325000.00 | $275000.00 | $258000.00 |
Gross Profit Ratio | $0.58 | $0.58 | $0.58 | $0.59 |
R&D Expenses | $81000.00 | $71000.00 | $69000.00 | $77000.00 |
SG&A Expenses | $871000.00 | $881000.00 | $845000.00 | $998000.00 |
Operating Expenses | $952000.00 | $952000.00 | $914000.00 | $1.07M |
Total Costs & Expenses | $1.12M | $1.18M | $1.11M | $1.26M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $70000.00 | $62000.00 | $52000.00 | $41000.00 |
Depreciation & Amortization | $1000.00 | $0.00 | $38000.00 | $36000.00 |
EBITDA | -$727000.00 | -$627000.00 | -$666000.00 | -$780000.00 |
EBITDA Ratio | -$1.86 | -$1.13 | -$1.41 | -$1.77 |
Operating Income | -$725000.00 | -$627000.00 | -$639000.00 | -$817000.00 |
Operating Income Ratio | -$1.85 | -$1.13 | -$1.35 | -$1.85 |
Other Income/Expenses (Net) | -$73000.00 | -$62000.00 | -$117000.00 | -$40000.00 |
Income Before Tax | -$798000.00 | -$689000.00 | -$756000.00 | -$857000.00 |
Income Before Tax Ratio | -$2.04 | -$1.24 | -$1.59 | -$1.94 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | -$798000.00 | -$689000.00 | -$756000.00 | -$857000.00 |
Net Income Ratio | -$2.04 | -$1.24 | -$1.59 | -$1.94 |
EPS | -$0.007 | -$0.006 | -$0.007 | -$0.008 |
Diluted EPS | -$0.007 | -$0.006 | -$0.007 | -$0.008 |
Weighted Avg Shares Outstanding | $111.86M | $111.86M | $111.86M | $111.86M |
Weighted Avg Shares Outstanding (Diluted) | $111.86M | $111.86M | $111.86M | $111.86M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan